XML 54 R44.htm IDEA: XBRL DOCUMENT v3.25.1
NOTE 10 - CAPITAL STOCK (Details) - USD ($)
12 Months Ended
Apr. 02, 2019
Mar. 31, 2018
Mar. 31, 2015
Mar. 30, 2015
Aug. 01, 2014
Dec. 06, 2011
Nov. 22, 2011
Dec. 31, 2018
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2019
Dec. 31, 2014
Common Stock, Shares Authorized                 100,000,000 100,000,000    
Common Stock, Par or Stated Value Per Share                 $ 0.0001 $ 0.0001    
Proceeds from issuance of restricted shares $ 14,490                      
Stock Issued During Period, Shares, Restricted Stock Award, Gross 21,000                      
Common Stock, Shares, Issued                 30,000,000 25,876,900 26,221,000  
Common Stock, Shares, Outstanding                 30,000,000 25,876,900 26,221,000  
Convertible Notes Payable                        
Due to Related Parties, Current               $ 470,935        
Redfield Holdings Ltd                        
Shares Issued               9,700        
Due to Related Parties, Current               $ 470,935        
GS Pharmaceuticals, Inc. | Convertible Notes Payable                        
Debt Instrument, Face Amount                       $ 330,000
Director                        
Shares Issued           1,200,000 25,000,000          
Shares Issued, Price Per Share           $ 0.000833 $ 0.0008          
Stock Issued During Period, Value, Issued for Services           $ 1,000 $ 20,000          
Preferred Class A                        
Preferred Stock, Shares Authorized                 20,000,000 20,000,000    
Preferred Stock, Par or Stated Value Per Share                 $ 0.0001 $ 0.0001    
Preferred Stock, Shares Issued                 10,000 10,000 10,000  
Preferred Stock, Shares Outstanding                 10,000 10,000 10,000  
Series A Preferred Stock                        
Preferred Stock, Shares Authorized                 10,000      
Series A Preferred Stock | Redfield Holdings Ltd                        
Shares Issued       9,700 300              
Shares Issued, Price Per Share         $ 1              
Debt Conversion, Converted Instrument, Amount       $ 58,000 $ 300              
Series B Preferred Stock                        
Redeemable Preferred Stock, Shares Issued                 330,000 330,000 330,000  
Redeemable Preferred Stock, Shares Outstanding                 330,000 330,000 330,000  
Series B Preferred Stock | GS Pharmaceuticals, Inc.                        
Debt Conversion, Converted Instrument, Shares Issued     330,000                  
Series C Preferred Stock                        
Redeemable Preferred Stock, Shares Issued                 470,935 470,935 470,935  
Redeemable Preferred Stock, Shares Outstanding                 470,935 470,935 470,935  
Series C Preferred Stock | Redfield Holdings Ltd                        
Debt Conversion, Converted Instrument, Shares Issued   470,935